Alnylam Pharmaceuticals
ALNY
$188.67
Share price
1.98%
Change (1 day)
49.98%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Stock price history for Alnylam Pharmaceuticals (ALNY)
Highest end of day price: $241.31 USD on 2022-12-21
Lowest end of day price: $3.95 USD on 2004-08-16
Stock price history of Alnylam Pharmaceuticals from 2004 to 2023
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Novartis NVS | $97.11 | 0.89% | 🇨🇭 Switzerland |
 Sanofi SNY | $50.46 | -1.10% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $731.17 | -0.60% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $124.28 | 0.55% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $1.33 | 2.31% | 🇺🇸 USA |
 OPKO Health
OPK | $1.40 | 0.72% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $7.20 | 0.00% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $34.67 | 0.76% | 🇺🇸 USA |